In the United States, the FDA considers the sale of unapproved peptide drugs for human use to be illegal
Multiple rounds of High-Performance Liquid Chromatography isolate our products by removing contaminating reagents and byproducts of synthesis
The 2.4 mg weekly maintenance dose is where the phase 3 monotherapy trials showed the strongest results, with an average body weight reduction of 11.8% over 68 weeks
We serve patients across New York, including New York City, Long Island, Buffalo, Albany, Rochester, Syracuse, Yonkers, White Plains, New Rochelle, Hempstead, Poughkeepsie, and surrounding communities
Evidence based on recent studies Initially, cases of intestinal obstruction associated with GLP-1 RAs were reported by the European Medicines Agency (EMA) in 2013 [9], and this safety signal is currently being monitored by the United States (US) FDA